{"name": "Novira Therapeutics",
 "permalink": "novira-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/novira-therapeutics",
 "homepage_url": "http://www.noviratherapeutics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2009,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@noviratherapeutics.com",
 "phone_number": "781-686-9947",
 "description": "antiviral therapeutics",
 "created_at": "Tue Apr 14 14:39:04 UTC 2009",
 "updated_at": "Fri Mar 29 04:42:31 UTC 2013",
 "overview": "\u003Cp\u003ENovira is focused on the discovery and development of first-in-class antiviral therapeutics. Based on emerging biology and proprietary insights on virus-host interactions, the company is working to develop novel small molecule drugs against medically-important viral targets.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       39],
      "assets/images/resized/0014/6325/146325v1-max-150x150.png"],
     [[250,
       65],
      "assets/images/resized/0014/6325/146325v1-max-250x250.png"],
     [[317,
       83],
      "assets/images/resized/0014/6325/146325v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$33M",
 "funding_rounds":
  [{"round_code": "seed",
    "source_url": "http://www.noviratherapeutics.com/Novira%20Press%20Release%20July%202011_final.pdf",
    "source_description": "Novira Therapeutics, Inc. Completes Second Round of Seed Financing with Philadelphia Angel Syndicate",
    "raised_amount": 2500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 7,
    "funded_day": 26,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Delaware Crossing Investor Group",
         "permalink": "delaware-crossing-investor-group",
         "image":
          {"available_sizes":
            [[[150,
               100],
              "assets/images/resized/0005/7728/57728v1-max-150x150.png"],
             [[179,
               120],
              "assets/images/resized/0005/7728/57728v1-max-250x250.png"],
             [[179,
               120],
              "assets/images/resized/0005/7728/57728v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Robin Hood Ventures",
         "permalink": "robin-hood-ventures",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0005/7727/57727v1-max-150x150.jpg"],
             [[250,
               83],
              "assets/images/resized/0005/7727/57727v1-max-250x250.jpg"],
             [[450,
               150],
              "assets/images/resized/0005/7727/57727v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://www.finsmes.com/2012/08/novira-therapeutics-secures-23m-series-financing.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Novira Therapeutics Secures $23M in Series A Financing",
    "raised_amount": 23000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 8,
    "funded_day": 24,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "5AM Ventures",
         "permalink": "5am-ventures",
         "image":
          {"available_sizes":
            [[[150,
               104],
              "assets/images/resized/0004/7316/47316v2-max-150x150.jpg"],
             [[250,
               173],
              "assets/images/resized/0004/7316/47316v2-max-250x250.jpg"],
             [[288,
               200],
              "assets/images/resized/0004/7316/47316v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Canaan Partners",
         "permalink": "canaan-partners-3",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0000/3958/3958v4-max-150x150.jpg"],
             [[250,
               82],
              "assets/images/resized/0000/3958/3958v4-max-250x250.jpg"],
             [[450,
               147],
              "assets/images/resized/0000/3958/3958v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "BioAdvance",
         "permalink": "bioadvance",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0005/6697/56697v1-max-150x150.jpg"],
             [[226,
               66],
              "assets/images/resized/0005/6697/56697v1-max-250x250.jpg"],
             [[226,
               66],
              "assets/images/resized/0005/6697/56697v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Mid Atlantic Angel Fund",
         "permalink": "mid-atlantic-angel-fund",
         "image":
          {"available_sizes":
            [[[150,
               35],
              "assets/images/resized/0004/5145/45145v1-max-150x150.png"],
             [[200,
               47],
              "assets/images/resized/0004/5145/45145v1-max-250x250.png"],
             [[200,
               47],
              "assets/images/resized/0004/5145/45145v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Robin Hood Ventures",
         "permalink": "robin-hood-ventures",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0005/7727/57727v1-max-150x150.jpg"],
             [[250,
               83],
              "assets/images/resized/0005/7727/57727v1-max-250x250.jpg"],
             [[450,
               150],
              "assets/images/resized/0005/7727/57727v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Delaware Crossing Investor Group",
         "permalink": "delaware-crossing-investor-group",
         "image":
          {"available_sizes":
            [[[150,
               100],
              "assets/images/resized/0005/7728/57728v1-max-150x150.png"],
             [[179,
               120],
              "assets/images/resized/0005/7728/57728v1-max-250x250.png"],
             [[179,
               120],
              "assets/images/resized/0005/7728/57728v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://www.fiercebiotech.com/story/versant-adds-75m-upstart-biotechs-round/2013-03-25?utm_source=rss\u0026utm_medium=rss",
    "source_description": "Versant adds $7.5M to upstart biotech's A round ",
    "raised_amount": 7500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 3,
    "funded_day": 25,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Versant Ventures",
         "permalink": "versant-ventures",
         "image":
          {"available_sizes":
            [[[150,
               30],
              "assets/images/resized/0004/6455/46455v2-max-150x150.jpg"],
             [[190,
               38],
              "assets/images/resized/0004/6455/46455v2-max-250x250.jpg"],
             [[190,
               38],
              "assets/images/resized/0004/6455/46455v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}